Forty-three patients with primary mucosal melanomas seen between 1960 and 1987 were reviewed. There were 17 patients with tumors arising from the head and neck, 17 from the vulva and/or vagina, 8 from the anorectum, and 1 from the esophagus. Twenty-one patients were resected with curative intent. In
Demographics and treatment trends in sinonasal mucosal melanoma
β Scribed by Thomas J. Gal; Natalie Silver; Bin Huang
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 284 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
β¦ Synopsis
Objectives/Hypothesis: To evaluate the population characteristics of mucosal melanoma of the nasal cavity and paranasal sinuses and determine the impact of the new staging classification.
Study Design: Analysis of a national database. Methods: Patients were identified from the Surveillance, Epidemiology, and End Results tumor registry data with mucosal melanoma of the nasal cavity and paranasal sinuses between 2000 and 2007. Tumors were classified using the American Joint Committee on Cancer (AJCC) 6th edition site-specific staging as well as 7th edition staging for head and neck mucosal melanoma (HNMM). Incidence rates and descriptive statistics were calculated, and multivariate analysis was performed to examine the impact of demographic factors and staging on survival.
Results: A total of 304 patients were identified. The incidence rate was 0.05 per 100,000. Fifty-six percent were female, 92% were >50 years old, and more than 90% were Caucasian; 81.6% of patients were treated with surgery, and 38.5% of patients received postoperative radiation. Overall, the 5-year survival rate was 24.2%. Significant differences in survival were observed for surgery with radiation (P ΒΌ .005) and surgery alone (P ΒΌ .04) compared with radiation alone. TNM staging using the AJCC 6th and 7th edition classification schemes yielded similar survival curves. However, the new classification for HNMM allows for better delineation of stage IV disease, revealing slightly improved survival for stage IVA disease.
Conclusions: HNMM is a rare disease with a poor prognosis. Surgery remains the treatment of choice, with some role for adjuvant therapy. The new staging classification for HNMM appears to more efficiently stage this disease. Demographics and therapeutic findings are discussed.
π SIMILAR VOLUMES
## Abstract Sinonasal mucosal melanomas are the most frequent mucosal melanomas and arise from melanocytes located in the nasal cavity and the paranasal sinuses. The melanoma types, cutaneous melanoma, uveal melanoma, and mucosal melanoma, differ in etiology, geographic distribution, and clinical b
## Abstract ## Background. No systemic therapy regimen has been recognized as effective for metastatic mucosal melanoma of the head and neck. We retrospectively analyzed the effectiveness of biochemotherapy in patients with advanced head and neck mucosal melanoma. ## Methods. We evaluated the me
## Abstract ## BACKGROUND Patients with metastatic anorectal melanoma generally have an unfavorable prognosis, but no effective systemic therapy has been reported. ## METHODS The authors retrospectively evaluated the medical records of all patients with metastatic anorectal melanoma treated with
Population-based rates for sinonasal cancer are examined in US mortality data among whites and in Connecticut incidence data. The observed rates are fitted to a log-linear model in order to examine the effect of each of the three variables, age, period and cohort, simultaneously for each sex. For Co
## Abstract The abrogation of the function of the βgatekeeper of the genomeβ, p53, is the most prevalent molecular alteration in solid human tumors. Regarding melanomas the involvement of __p53__ alterations is discussed controversially to date. In order to evaluate the status of p53 in detail, pri